Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -94,179 | -59,492 | -26,033 | -138,885 | -104,813 |
| Depreciation Amortization | 7,504 | 6,594 | 3,330 | 9,426 | 6,605 |
| Accounts receivable | -8,091 | -2,297 | -2,021 | 8,967 | 2,272 |
| Accounts payable and accrued liabilities | 1,784 | 838 | -578 | -12,975 | -12,887 |
| Other Working Capital | -14,048 | -14,519 | -15,595 | -29,197 | -37,212 |
| Other Operating Activity | 33,877 | 17,925 | 10,614 | 19,210 | 16,640 |
| Operating Cash Flow | $-73,153 | $-50,951 | $-30,283 | $-143,454 | $-129,395 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 62,759 | 49,071 | 19,679 | 92,881 | 62,388 |
| PPE Investments | -7,827 | -6,941 | -5,054 | -8,355 | -4,973 |
| Net Acquisitions | N/A | N/A | N/A | 278,648 | 280,033 |
| Purchase Of Investment | -19,483 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $35,449 | $42,130 | $14,625 | $363,174 | $337,448 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -63,192 | -8,192 |
| Common Stock Issued | 308 | 308 | N/A | 2,070 | 1,545 |
| Common Stock Repurchased | N/A | N/A | N/A | -40,490 | -40,490 |
| Other Financing Activity | -358 | -246 | -46 | -1,004 | -959 |
| Financing Cash Flow | $-50 | $62 | $-46 | $-102,616 | $-48,096 |
| Exchange Rate Effect | 942 | 1,145 | 357 | -785 | -518 |
| Beginning Cash Position | 168,818 | 168,818 | 168,818 | 52,499 | 52,499 |
| End Cash Position | 132,006 | 161,204 | 153,471 | 168,818 | 211,938 |
| Net Cash Flow | $-36,812 | $-7,614 | $-15,347 | $116,319 | $159,439 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,153 | -50,951 | -30,283 | -143,454 | -129,395 |
| Capital Expenditure | -7,827 | -6,941 | -5,054 | -8,355 | -4,973 |
| Free Cash Flow | -80,980 | -57,892 | -35,337 | -151,809 | -134,368 |